Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

SCT200

Catalog No. T9901A-1707 Copy Product Info
🥰Excellent
SCT200 is a fully humanized IgG1 monoclonal antibody targeting EGFR, with a Kd value of 0.08 nM. It can eliminate tumor cells via complement-dependent cytotoxicity (CDC) and antibody-dependent cellular cytotoxicity (ADCC) through its Fc fragment. SCT200 is utilized in research on refractory RAS and BRAF wild-type metastatic colorectal cancer.

SCT200

Copy Product Info
🥰Excellent
Catalog No. T9901A-1707

SCT200 is a fully humanized IgG1 monoclonal antibody targeting EGFR, with a Kd value of 0.08 nM. It can eliminate tumor cells via complement-dependent cytotoxicity (CDC) and antibody-dependent cellular cytotoxicity (ADCC) through its Fc fragment. SCT200 is utilized in research on refractory RAS and BRAF wild-type metastatic colorectal cancer.

SCT200
Pack SizePriceUSA StockGlobal StockQuantity
1 mgInquiryInquiryInquiry
5 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
SCT200 is a fully humanized IgG1 monoclonal antibody targeting EGFR, with a Kd value of 0.08 nM. It can eliminate tumor cells via complement-dependent cytotoxicity (CDC) and antibody-dependent cellular cytotoxicity (ADCC) through its Fc fragment. SCT200 is utilized in research on refractory RAS and BRAF wild-type metastatic colorectal cancer.
Chemical Properties
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy SCT200 | purchase SCT200 | SCT200 cost | order SCT200